THERABIOGEN, INC. Stock-Based Compensation
THERABIOGEN, INC. reported Stock-Based Compensation of $2.66 million for the 12-month period ending 2012-02-29, per its 10-K/A filed 2012-07-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-07-23
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-02-29 was -$17.74K.
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2011-11-30 was $427.25K.
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2011-08-31 was $79.08K.
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2011-05-31 was $2.17M.
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for fiscal 2012 was $2.66M, a 73.60% increase from fiscal 2011.
- THERABIOGEN, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $1.53M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-02-29 | -$17.74K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $409.50K derived: sum of 2 quarters · filed 2012-07-18 | $488.58K derived: sum of 3 quarters · filed 2012-07-18 | $2.66M 10-K/A · filed 2012-07-18 |
| 2011-11-30 | $427.25K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-17 | $506.33K derived: sum of 2 quarters · filed 2012-01-17 | $2.68M 10-Q · filed 2012-01-17 | |
| 2011-08-31 | $79.08K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-11-17 | $2.25M 10-Q/A · filed 2011-11-17 | ||
| 2011-05-31 | $2.17M 10-Q · filed 2012-07-23 | |||
| 2011-02-28 | $1.53M 10-K/A · filed 2012-07-18 |